Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic Brosseron

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Alzheimer'S Research & Therapy|February 28, 2018
Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer's diseaseFrederic Brosseron, Andreas Traschütz, Catherine N Widmann, et al.
Journal of Neurochemistry|December 25, 2019
Soluble Aβ oligomers and protofibrils induce NLRP3 inflammasome activation in microgliaAsta Lučiūnaitė, Róisín M McManus, Marija Jankunec, et al.
Journal of Neurochemistry|September 15, 2019
Quantitative proteomics of synaptosome S-nitrosylation in Alzheimer's diseaseTeodora Stella Wijasa, Marc Sylvester, Nahal Brocke-Ahmadinejad, et al.
Journal of Neurochemistry|September 7, 2020
Interrelations of Alzheimer´s disease candidate biomarkers neurogranin, fatty acid-binding protein 3 and ferritin to neurodegeneration and neuroinflammationFrederic Brosseron, Kilian Kleemann, Carl-Christian Kolbe, et al.
The Journal of Prevention of Alzheimer'S Disease|April 5, 2026
Dementia risk factor assessment in a local Alzheimer's prevention population: a German cross-sectional, observational studyLena Sannemann, Michelle Gerards, Lara Bohr, et al.
Alzheimer'S Research & Therapy|July 31, 2024
Assessing blood-brain barrier dysfunction and its association with Alzheimer's pathology, cognitive impairment and neuroinflammationLukas Preis, Kersten Villringer, Frederic Brosseron, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 11, 2025
Prospective Multicenter Evaluation of the MDS "Suggestive of PSP" Diagnostic CriteriaAndrea Quattrone, Nicolai Franzmeier, Johannes Levin, et al.
Proteomics. Clinical Applications|August 30, 2012
Stepwise isolation of human peripheral erythrocytes, T lymphocytes, and monocytes for blood cell proteomicsFrederic Brosseron, Caroline May, Bodo Schoenebeck, et al.
Glia|November 14, 2022
Reactive microglia are the major source of tumor necrosis factor alpha and contribute to astrocyte dysfunction and acute seizures in experimental temporal lobe epilepsyLukas Henning, Henrike Antony, Annika Breuer, et al.
JMIR Research Protocols|September 24, 2021
Longitudinal Neurocognitive and Pulmonological Profile of Long COVID-19: Protocol for the COVIMMUNE-Clin StudyCatherine N Widmann, Michelle Wieberneit, Luzie Bieler, et al.
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Alzheimer'S Research & Therapy|February 28, 2018
Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer's diseaseFrederic Brosseron, Andreas Traschütz, Catherine N Widmann, et al.
Journal of Neurochemistry|December 25, 2019
Soluble Aβ oligomers and protofibrils induce NLRP3 inflammasome activation in microgliaAsta Lučiūnaitė, Róisín M McManus, Marija Jankunec, et al.
Journal of Neurochemistry|September 15, 2019
Quantitative proteomics of synaptosome S-nitrosylation in Alzheimer's diseaseTeodora Stella Wijasa, Marc Sylvester, Nahal Brocke-Ahmadinejad, et al.
Journal of Neurochemistry|September 7, 2020
Interrelations of Alzheimer´s disease candidate biomarkers neurogranin, fatty acid-binding protein 3 and ferritin to neurodegeneration and neuroinflammationFrederic Brosseron, Kilian Kleemann, Carl-Christian Kolbe, et al.
The Journal of Prevention of Alzheimer'S Disease|April 5, 2026
Dementia risk factor assessment in a local Alzheimer's prevention population: a German cross-sectional, observational studyLena Sannemann, Michelle Gerards, Lara Bohr, et al.
Alzheimer'S Research & Therapy|July 31, 2024
Assessing blood-brain barrier dysfunction and its association with Alzheimer's pathology, cognitive impairment and neuroinflammationLukas Preis, Kersten Villringer, Frederic Brosseron, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 11, 2025
Prospective Multicenter Evaluation of the MDS "Suggestive of PSP" Diagnostic CriteriaAndrea Quattrone, Nicolai Franzmeier, Johannes Levin, et al.
Proteomics. Clinical Applications|August 30, 2012
Stepwise isolation of human peripheral erythrocytes, T lymphocytes, and monocytes for blood cell proteomicsFrederic Brosseron, Caroline May, Bodo Schoenebeck, et al.
Glia|November 14, 2022
Reactive microglia are the major source of tumor necrosis factor alpha and contribute to astrocyte dysfunction and acute seizures in experimental temporal lobe epilepsyLukas Henning, Henrike Antony, Annika Breuer, et al.
JMIR Research Protocols|September 24, 2021
Longitudinal Neurocognitive and Pulmonological Profile of Long COVID-19: Protocol for the COVIMMUNE-Clin StudyCatherine N Widmann, Michelle Wieberneit, Luzie Bieler, et al.
Pageof 11